Bachem

Bachem is a Swiss biotechnology firm that specializes in chemistry, biochemistry, and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active medicinal components, the creation of peptide-based biochemicals, and the development of these substances' manufacturing techniques.

With over 50 years of experience and knowledge, Bachem serves pharmaceutical and biotechnology firms worldwide with products for research, clinical development, and commercial application, as well as a broad spectrum of services. Bachem works on a global scale, with headquarters in Switzerland and offices in Europe, the United States, and Asia.

Its medications are used to treat a variety of diseases, including central nervous system problems, metabolic disorders, cancer, and infectious infections. Catalog products and fluorescent dyes are among the company's research products. NCEs, small molecules APIS, and generic APIs are among its active pharmaceutical ingredients.

Founded: 1971

Headquarters: Bubendorf, Switzerland

Website: https://www.bachem.com/